Considering that reduced infiltration of MDSCs has been reported to correlate with increased sensitivity to immunotherapy efficacy in various cancer types [11, 14], we sought to test whether overexpression of USP25 augments anti-PD-1 therapy efficacy in HNSCC. Here, USP25 is linked to head and neck squamous cell carcinoma.